Text Messaging Intervention to Improve ART Adherence among HIV-positive Youth
Text Messaging Intervention to Improve ART Adherence among HIV-positive Youth
批准号:
8311781
负责人:
Robert Garofalo
金额:
$20.94万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2014-05-31
关键词:
AdherenceAgeAlcohol or Other Drugs useAlcoholsBiological MarkersCD4 Lymphocyte CountCellular PhoneClinicClinical TrialsControl GroupsDataEffectivenessEnrollmentFeasibility StudiesGenetic Crossing OverHIVHIV SeropositivityInfectionInterventionIntervention TrialLifeMeasuresMinorityOutcomeParticipantPatientsPharmaceutical PreparationsPopulation DecreasesPopulation StudyRandomizedRandomized Clinical TrialsRandomized Controlled TrialsReportingSample SizeSamplingScheduleServicesSiteTechnologyTestingTextTransfusionViral Load resultVisualYouthadolescent substance useanalogburden of illnesscontrol trialeffective interventionfollow-upgroup interventionhigh riskimprovedintervention effectmedication compliancepost interventionpractical applicationprimary outcomeresponsesatisfactionsecondary outcomestandard of careyoung adult
中文摘要
正如PAS-10-098所强调的,感染艾滋病毒的青年是一个脆弱的亚群。大多数
YLH是少数群体,可能使用非法药物,并且经常与艾滋病毒的坚持斗争
药物治疗提出研究的目的是为了测试短信短信技术的改进
YLH中的药物依从性。这项研究是一项随机对照试验的影响,文本
在年龄16-29岁的非依从性YLH患者中,关于ART依从性的信息提醒。每日短信提醒
将根据患者的用药时间表随机分配至干预组,
个月一项小型可行性研究(N=25),包括高比例的需要酒精和/或药物的青年
处理(即,60%),提供了这种方法的潜在有效性的初步证据。我们将
招募152名年龄在16-29岁的非依从性YLH。随机分配至干预组的一半样本(N=76)将
每天收到短信提醒服药,一半将被随机分配到对照组
(N=76),仅接受标准治疗(SOC)。对于对照试验,将对依从性水平和病毒载量进行评估。
在基线、3个月和6个月随访时收集。此外,在最初6个月的入组结束时,
期间,控制条件下的参与者将交叉到SMS干预和
干预条件将停止接收SMS干预。依从性和病毒载量数据将
在9个月和12个月随访时从每组中收集。这些附加功能的优点
它们允许我们向所有参与者提供干预,以评估控制中的干预效果,
对干预组的干预效果进行确认,并对干预组的持续干预效果进行评估
(干预后)。我们假设,处于干预条件下的年轻人将表现出临床上的
基线后3个月和6个月时依从性有意义的增加,从约70%增加至90%
我们的具体目标是:1)确定短信干预的有效性
我们的主要结果:在16-29岁的YLH中,对ART的依从性较差(一组显示为
高风险的物质使用)超过6个月的干预期; 2)探索短信文本的功效
对次要探索性结局(病毒载量和CD 4计数)的消息传递干预,为期6个月
干预期; 3)评估该干预和临床的可行性,可接受性和满意度
通过客观和主观的衡量标准进行审判。我们的主要假设是:1)年轻人随机分配到
SMS短信干预将显示ART依从性水平的更大改善,
基线后3个月和6个月干预期间的次要结局,与
仅接收SOC。我们假设3和6岁组之间的依从性水平有10分的差异
个月的干预是有临床意义的; 2)青年随机短信
干预将保持改进(即,在9个月和12个月随访时,依从性> 90%。
英文摘要
As emphasized in PAS-10-098, youth living with HIV (YLH) are a vulnerable subpopulation. The majority of
YLH are of minority status, are likely to use illicit substances, and often struggle with adherence to HIV
medications. The purpose of the proposed study is to test SMS text messaging technology to improve
medication adherence among YLH. The proposed study is a randomized controlled trial of the effect of text
message reminders on ART adherence among non-adherent YLH, ages 16-29. Daily text message reminders
will be sent to patients randomized to the intervention group according to their medication schedule, for 6
months. A small feasibility study (N=25), including a high percentage of youth in need of alcohol and/or drug
treatment (i.e., 60%), provided preliminary evidence of the potential effectiveness of this approach. We will
enroll 152 non-adherent YLH, ages 16-29. Half of the sample (N=76), randomized to the intervention, will
receive daily SMS text message medication reminders and half will be randomized to the control condition
(N=76) and receive standard of care (SOC) only. For the controlled trial, adherence levels and viral load will be
collected at baseline, 3-month and 6-month follow-up. In addition, at the end of the initial 6-month enrollment
period, participants in the control condition will cross-over to the SMS intervention and participants in the
intervention condition will cease to receive the SMS intervention. Adherence and viral load data will be
collected from each group at 9- and 12-month follow-up points. The advantages of these additional features
are that they allow us to offer the intervention to all participants, to evaluate the intervention effect in the control
group (to confirm the intervention effect) and to assess sustained intervention effects in the intervention group
(post-intervention). We hypothesize that youth in the intervention condition will demonstrate a clinically
meaningful increase in adherence at 3 and 6 months post-baseline, from approximately 70% to 90%
adherence to ART. Our specific aims are: 1) to determine the efficacy of an SMS text messaging intervention
on our primary outcome: adherence to ART among poorly adherent YLH, ages 16-29 (a group shown to be at
high risk for substance use) over a 6-month intervention period; 2) to explore the efficacy of an SMS text
messaging intervention on a secondary, exploratory outcome: viral load and CD4 counts, over a 6-month
intervention period; 3) to assess the feasibility, acceptability, and satisfaction of this intervention and clinical
trial approach by both objective and subjective measures. Our primary hypotheses are: 1) youth randomized to
the SMS text messaging intervention will show greater improvements in levels of adherence to ART and
secondary outcomes during the intervention period at 3 and 6 months post-baseline, in comparison to those
receiving SOC only. We hypothesize a 10-point difference in adherence level between groups at 3 and 6
months for the intervention to be clinically meaningful; 2) youth randomized to SMS text messaging
intervention will maintain improvements (i.e., > 90% adherence) at 9-month and 12-month follow-ups.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1007/s10461-015-1192-x
发表时间:
2016-05
期刊:
AIDS and behavior
影响因子:
4.4
作者:
[Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D]
通讯作者:
Rice D
Intensive Combination Approach to Rollback the HIV Epidemic in Nigerian Youth (iCARE) Plus Effectiveness / Implementation Hybrid Study
-
批准号:10749347
-
项目类别:
-
资助金额:$141.02万
-
财政年份:2023
-
负责人:Robert Garofalo
-
依托单位:
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
-
批准号:10818851
-
项目类别:
-
资助金额:$116.46万
-
财政年份:2023
-
负责人:Robert Garofalo
-
依托单位:
Development and Testing of MyPEEPS Mobile for Young Transgender Men
-
批准号:10544319
-
项目类别:
-
资助金额:$31.92万
-
财政年份:2022
-
负责人:Robert Garofalo
-
依托单位:
Development and Testing of MyPEEPS Mobile for Young Transgender Men
-
批准号:10407736
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2022
-
负责人:Robert Garofalo
-
依托单位:
Intensive Combination Approach to Rollback the Epidemic (iCARE) in Nigerian Adolescents
-
批准号:10046115
-
项目类别:
-
资助金额:$37.64万
-
财政年份:2020
-
负责人:Robert Garofalo
-
依托单位:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
-
批准号:9927670
-
项目类别:
-
资助金额:$81.64万
-
财政年份:2018
-
负责人:Robert Garofalo
-
依托单位:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
-
批准号:10404092
-
项目类别:
-
资助金额:$77.24万
-
财政年份:2018
-
负责人:Robert Garofalo
-
依托单位:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
-
批准号:10160957
-
项目类别:
-
资助金额:$81.58万
-
财政年份:2018
-
负责人:Robert Garofalo
-
依托单位:
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to Care
-
批准号:9755512
-
项目类别:
-
资助金额:$82.92万
-
财政年份:2018
-
负责人:Robert Garofalo
-
依托单位:
Adaptive intervention strategies trial for strengthening adherence to antiretroviral HIV treatment among youth
-
批准号:10371803
-
项目类别:
-
资助金额:$59.15万
-
财政年份:2016
-
负责人:Robert Garofalo
-
依托单位:
Adaptive intervention strategies trial for strengthening adherence to antiretroviral HIV treatment among youth
-
批准号:9357686
-
项目类别:
-
资助金额:$62.78万
-
财政年份:2016
-
负责人:Robert Garofalo
-
依托单位:
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV prevention Behaviors in Diverse Adolescent MSM
-
批准号:9902191
-
项目类别:
-
资助金额:$157.58万
-
财政年份:2016
-
负责人:Robert Garofalo
-
依托单位:
A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV prevention Behaviors in Diverse Adolescent MSM
-
批准号:9569861
-
项目类别:
-
资助金额:$7.96万
-
财政年份:2016
-
负责人:Robert Garofalo
-
依托单位:
Employing eSBI in a Community-based HIV Testing Environment for At-risk Youth
-
批准号:9054477
-
项目类别:
-
资助金额:$64.08万
-
财政年份:2015
-
负责人:Robert Garofalo
-
依托单位:
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
-
批准号:9247834
-
项目类别:
-
资助金额:$47.74万
-
财政年份:2013
-
负责人:Robert Garofalo
-
依托单位:
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
-
批准号:8556766
-
项目类别:
-
资助金额:$69.15万
-
财政年份:2013
-
负责人:Robert Garofalo
-
依托单位:
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
-
批准号:8650296
-
项目类别:
-
资助金额:$59.38万
-
财政年份:2013
-
负责人:Robert Garofalo
-
依托单位:
CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
-
批准号:8826797
-
项目类别:
-
资助金额:$60.29万
-
财政年份:2013
-
负责人:Robert Garofalo
-
依托单位:
HIV Prevention Intervention for Young Transgender Women
-
批准号:8215419
-
项目类别:
-
资助金额:$74.22万
-
财政年份:2011
-
负责人:Robert Garofalo
-
依托单位:
HIV Prevention Intervention for Young Transgender Women
-
批准号:8457098
-
项目类别:
-
资助金额:$74.92万
-
财政年份:2011
-
负责人:Robert Garofalo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: